Critical Path Institute’s Translational Therapeutics Accelerator Awards $150,000 Grant to Support a Novel Drug Approach in Hereditary Spastic Paraplegia
TUCSON, Ariz., August 7, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) has awarded
